The widespread use of GLP-1 therapies, particularly in obesity, has raised questions about appropriate prescribing, long-term safety, and equitable access
Suggestive but not conclusive evidence preclinical studies, small clinical trials, and anecdotal reports has found that GLP-1 agonists might improve memory, reduce rates of dementia, and more, suggesting they may be effective Alzheimers treatments
Adverse event frequency, although not statistically different between groups, was somewhat higher in the treatment group, particularly with regard to gastrointestinal and respiratory symptoms
Purchasing Supplements When purchasing supplements reviewed on this web site and discussed with Dr
Lovells experience with the medication is one of countless success stories to emerge amid a monumental shift in the way people lose weight and, consequently, how they live and spend
In that context, the researchers examined the insurance claims of nearly 3,600 pregnancies among women taking GLP-1s, some of whom continued to do so during the first trimester of pregnancy and some of whom stopped